Regeneron Pharmaceuticals Inc. stock falls Friday, underperforms
Shares of Regeneron Pharmaceuticals Inc.
REGN,
dropped 0.43% to $553.24 Friday, on what proved to be an all-around favorable trading session for the stock market, with the S&P 500 Index
SPX,
rising 0.75% to 4,471.37 and the Dow Jones Industrial Average
DJIA,
rising 1.09% to 35,294.76. The stock’s fall snapped a two-day winning streak. Regeneron Pharmaceuticals Inc. closed $133.38 short of its 52-week high ($686.62), which the company reached on September 3rd.
The stock underperformed when compared to some of its competitors Friday, as Johnson & Johnson
JNJ,
rose 0.74% to $161.30, Novartis AG ADR
NVS,
rose 0.88% to $83.33, and Amgen Inc.
AMGN,
rose 0.51% to $207.84. Trading volume (828,624) eclipsed its 50-day average volume of 781,432.
Editor’s Note: This story was auto-generated by Automated Insights, an automation technology provider, using data from Dow Jones and FactSet. See our market data terms of use.
Read More: Regeneron Pharmaceuticals Inc. stock falls Friday, underperforms